Commentary: Real-world neoadjuvant immunochemotherapy for lung cancer: Additional data but still many questions Editorial

  

Author:	Rusch, V. W.
Title:	Commentary: Real-world neoadjuvant immunochemotherapy for lung cancer: Additional data but still many questions
Keywords:	epidermal growth factor; treatment outcome; treatment response; histopathology; mortality; disease free survival; chemotherapy, adjuvant; neoadjuvant therapy; carcinoma, non-small-cell lung; lung neoplasms; pneumonectomy; editorial; pathology; lung tumor; immunotherapy; adjuvant chemotherapy; neoadjuvant chemotherapy; drug therapy; therapy; programmed death 1 ligand 1; non small cell lung cancer; pathological complete response; clinical trial (topic); adverse event; procedures; chemoimmunotherapy; immune checkpoint inhibitor; humans; human; circulating tumor dna
Journal Title:	Journal of Thoracic and Cardiovascular Surgery
Volume:	168
Issue:	4
ISSN:	0022-5223
Publisher:	Mosby Elsevier
Date Published:	2024-10-01
Start Page:	1259
End Page:	1260
Language:	English
DOI:	10.1016/j.jtcvs.2024.03.008
PUBMED:	38492721
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190276952&doi=10.1016%2fj.jtcvs.2024.03.008&partnerID=40&md5=14018a86c273141c1b1443a5cd9a40c8
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/219300